Catalyst Event
Eli Lilly and Co (LLY) · Earnings Release
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
8/6/2026, 12:00:00 AM
Eli Lilly's Q2 2026 quarterly earnings release, estimated as high importance due to being a primary volatility driver with a likely >=10% price impact, is scheduled.
Korean Translation
일라이 릴리의 2026년 2분기 분기 실적 발표는 주요 변동성 요인으로 10% 이상의 주가 영향이 전망되어 예정됨.
Related Recent Events
Boston Scientific Corp (BSX) · Earnings Release
Q2 2026 earnings release and conference call on July 29, 2026, scheduled.
7/29/2026, 12:00:00 AM
3SBio Inc (1530) · Other
Ex-dividend date for the final dividend of HK$0.25 per share on 2026-07-20 scheduled, with payment on 2026-08-04; low importance as dividend adjustments typically result in <5% price impact.
7/20/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Annual General Meeting (AGM) on June 16, 2026, to approve the annual report and dividend payout for the fiscal year; medium importance as a standard corporate governance event confirming shareholder returns, scheduled.
6/16/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic is scheduled to report financial results for its fourth quarter and full fiscal year 2026 on June 3, 2026. This is a future event, so importance is an estimate based on the typical high impact of full-year earnings reports, scheduled
6/3/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date on June 3, 2026 for a proposed final dividend of RMB 0.5390 and a special dividend of RMB 0.6714 (AGM: May 28, Record Date: June 8); ≥5% price impact scheduled.
6/3/2026, 12:00:00 AM
Johnson & Johnson (JNJ) · Other
Quarterly dividend of $1.34 per share to go ex-dividend on May 26, 2026. The 3.1% increase was announced on April 14, 2026, scheduled.
5/26/2026, 12:00:00 AM